is retatrutide safe for type 1 diabetes Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide vs. Tirzepatide: The Next-Gen

While studies sponsored by leading pharmaceutical companies suggest a much higher likelihood of weight regain, those studies are not reflective of the average person with obesity

Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones Metabol (2016) 48(7):47683

Sep 2024 - Global pharmaceutical company Amneal Pharmaceuticals, Inc., and clinical-stage biopharmaceutical company Metsera, Inc., are accelerating next-generation medicines for obesity and metabolic diseases by joining forces with a portfolio of new weight loss medicines on efficient development and large-scale supply worldwide

Retatrutide is investigational and meets neither requirement